ANGLE plc is a United Kingdom-based holding company. The Company is a specialist medical diagnostic company, which offers products for cancer diagnostics and fetal health. Its lead product is Parsortix cell separation system, which can capture circulating tumor cells (CTCs) in cancer patient blood even when there is less than one CTC in one billion healthy cells. The resulting liquid biopsy enables the investigation of mutations in the patient's cancer for personalized cancer care. The Parsortix GEN3 Cassette is able to capture circulating tumor cells in cancer patient blood and works with a variety of cancers, including ovarian, prostate, breast, lung, colorectal, pancreatic and renal. The Company manages any overseas research, development (R&D), sales, and marketing from the United Kingdom segment. The Company's subsidiaries include ANGLE Europe Limited, ANGLE North America Inc, ANGLE Technology Limited, ANGLE Partnerships Limited and ANGLE Technology Licensing Limited.